A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
暂无分享,去创建一个
P. Newton | M. Mayxay | Maniphone Khanthavong | P. Tabernero | M. Green | I. Swamidoss | Chindaphone Phonlavong | Chanvilay Sichanh | S. Sengaloundeth | Chanthala Vilayhong
[1] P. Newton,et al. Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: evidence to inform policy , 2021, BMJ Global Health.
[2] Uniformity of Dosage Units , 2020, Definitions.
[3] I. Kibwage,et al. The quality of anti-malarial medicines in Embu County, Kenya , 2018, Malaria Journal.
[4] Stephan Sanders,et al. Pharmacopoeia , 2018, Oxford Handbook for the Foundation Programme.
[5] B. Meessen,et al. Pharmaceutical quality assurance of local private distributors: a secondary analysis in 13 low-income and middle-income countries , 2018, BMJ Global Health.
[6] Sarah L. Bliese,et al. Amoxicillin Quality and Selling Practices in Urban Pharmacies and Drug Stores of Blantyre, Malawi. , 2018, The American journal of tropical medicine and hygiene.
[7] J. Nwokike,et al. Medicines quality assurance to fight antimicrobial resistance , 2017, Bulletin of the World Health Organization.
[8] P. Newton,et al. Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People’s Democratic Republic , 2017, Drug Safety.
[9] D. V. van Schalkwyk,et al. Degradation of Artemisinin-Based Combination Therapies under Tropical Conditions , 2016, The American journal of tropical medicine and hygiene.
[10] W. Ba-Thein,et al. Pharmacopoeial quality of antimicrobial drugs in southern China. , 2016, The Lancet. Global health.
[11] Luke S P Moore,et al. Antimicrobials: access and sustainable eff ectiveness 2 Understanding the mechanisms and drivers of antimicrobial resistance , 2015 .
[12] H. Kaur,et al. Quality of the Antibiotics—Amoxicillin and Co-Trimoxazole from Ghana, Nigeria, and the United Kingdom , 2015, The American journal of tropical medicine and hygiene.
[13] P. Newton,et al. Collaborative Health and Enforcement Operations on the Quality of Antimalarials and Antibiotics in Southeast Asia , 2015, The American journal of tropical medicine and hygiene.
[14] P. Newton,et al. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better , 2015, The American journal of tropical medicine and hygiene.
[15] Fabrice Quet,et al. Antibiotic prescription behaviours in Lao People's Democratic Republic: a knowledge, attitude and practice survey , 2015, Bulletin of the World Health Organization.
[16] P. Newton,et al. Colonization with Enterobacteriaceae producing ESBLs in children attending pre-school childcare facilities in the Lao People's Democratic Republic , 2015, The Journal of antimicrobial chemotherapy.
[17] J. Roberts,et al. Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development , 2015, Seminars in Respiratory and Critical Care Medicine.
[18] Nicola Ranieri,et al. Evaluation of a New Handheld Instrument for the Detection of Counterfeit Artesunate by Visual Fluorescence Comparison , 2014, The American journal of tropical medicine and hygiene.
[19] P. Newton,et al. Falsified medicines in Africa: all talk, no action. , 2014, The Lancet. Global health.
[20] H. Tsuboi,et al. A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010 , 2014, BMC Pharmacology and Toxicology.
[21] B. Venhuis,et al. Dose-to-dose variations with single packages of counterfeit medicines and adulterated dietary supplements as a potential source of false negatives and inaccurate health risk assessments. , 2014, Journal of pharmaceutical and biomedical analysis.
[22] Atholl Johnston,et al. Substandard drugs: a potential crisis for public health , 2013, British journal of clinical pharmacology.
[23] H. Tsuboi,et al. Effects of packaging and storage conditions on the quality of amoxicillin-clavulanic acid – an analysis of Cambodian samples , 2013, BMC Pharmacology and Toxicology.
[24] F. Fernández,et al. High throughput quantitation of artesunate and its degradation products by flow injection gradient ratio standard addition mass spectrometry (FI-GRSA-MS) , 2012 .
[25] A. Carpentier,et al. Update on counterfeit antibiotics worldwide; public health risks. , 2012, Medecine et maladies infectieuses.
[26] P. Newton,et al. Characteristics of CTX-M ESBL-producing Escherichia coli isolates from the Lao People's Democratic Republic, 2004–09 , 2011, The Journal of antimicrobial chemotherapy.
[27] P. Newton,et al. Urine Antibiotic Activity in Patients Presenting to Hospitals in Laos: Implications for Worsening Antibiotic Resistance , 2011, The American journal of tropical medicine and hygiene.
[28] P. Böelle,et al. Antibiotic Dose Impact on Resistance Selection in the Community: a Mathematical Model of β-Lactams and Streptococcus pneumoniae Dynamics , 2010, Antimicrobial Agents and Chemotherapy.
[29] M. Rowland,et al. Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003 , 2009, Emerging infectious diseases.
[30] Christina Y Hampton,et al. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR – implications for therapeutic failure and drug resistance , 2009, Malaria Journal.
[31] P. Newton,et al. Guidelines for Field Surveys of the Quality of Medicines: A Proposal , 2009, PLoS medicine.
[32] C. Mace,et al. Substandard medicines in resource‐poor settings: a problem that can no longer be ignored , 2008, Tropical medicine & international health : TM & IH.
[33] P. Newton,et al. Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether. , 2008, The American journal of tropical medicine and hygiene.
[34] Christina Y Hampton,et al. A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia , 2008, PLoS medicine.
[35] Matthew E Falagas,et al. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. , 2007, The Journal of antimicrobial chemotherapy.
[36] P. Preux,et al. Availability and Costs of Antiepileptic Drugs and Quality of Phenobarbital in Vientiane Municipality, Lao PDR , 2007, Neuroepidemiology.
[37] Henry Nettey,et al. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. , 2007, Journal of pharmaceutical and biomedical analysis.
[38] D. Socheat,et al. Counterfeit and substandard antimalarial drugs in Cambodia. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[39] Paul N Newton,et al. Counterfeit anti-infective drugs. , 2006, The Lancet. Infectious diseases.
[40] P. Newton,et al. Manslaughter by Fake Artesunate in Asia—Will Africa Be Next? , 2006, PLoS medicine.
[41] Akio Nishimura,et al. Rational use of drugs: prescribing and dispensing practices at public health facilities in Lao PDR , 2006, Pharmacoepidemiology and drug safety.
[42] Peter Aldhous,et al. Counterfeit pharmaceuticals: Murder by medicine , 2005, Nature.
[43] B. Lindgren,et al. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999 , 2004, Pharmacy World and Science.
[44] M. Mayxay,et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarials , 2004, Tropical medicine & international health : TM & IH.
[45] S. Singh,et al. A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[46] Stephane Proux,et al. Fake artesunate in southeast Asia , 2001, The Lancet.
[47] O. Shakoor,et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies , 2001, The Lancet.
[48] T. Kenyon,et al. Substandard tuberculosis drugs on the global market and their simple detection. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[49] I. Okeke,et al. Antimicrobial resistance in developing countries , 1998, BMJ.
[50] H. Hogerzeil,et al. The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study , 1998, BMJ.
[51] Remi Verduin‐Muttiganzi,et al. Assessment of the incidence of substandard drugs in developing countries , 1998, Tropical medicine & international health : TM & IH.
[52] O. Shakoor,et al. Assessment of the incidence of substandard drugs in developing countries , 1997, Tropical medicine & international health : TM & IH.
[53] F. Ballereau,et al. Stability of essential drugs in the field: results of a study conducted over a two-year period in Burkina Faso. , 1997, The American journal of tropical medicine and hygiene.
[54] W. Thomson. The International Pharmacopoeia. , 1952, The Practitioner.
[55] A. Hirschfelder. THE UNITED STATES PHARMACOPEIAL CONVENTION , 1930 .
[56] Mario Prost. System , 2019, Concepts for International Law.
[57] A. Attaran,et al. Fatal Bacterial Meningitis Possibly Associated with Substandard Ceftriaxone--Uganda, 2013. , 2016, MMWR. Morbidity and mortality weekly report.
[58] E. Pisani. Antimicrobial resistance : What does medicine quality have to do with it ? , 2015 .
[59] C. Jentgen,et al. Country profile on Lao People's Democratic Republic , 2003 .
[60] B. Lindgren,et al. The quality of drugs in private pharmacies in the Lao People’s Democratic Republic , 1998 .
[61] G. Tomson,et al. Pharmaceutical regulation in context: the case of Lao People's Democratic Republic. , 1997, Health policy and planning.